Genetic markers of oxidative stress and coronary atherosclerosis

被引:15
作者
Madamanchi N.R. [1 ]
Tchivilev I. [1 ]
Runge M.S. [1 ]
机构
[1] Department of Medicine, University of North Carolina, Chapel Hill, NC 27599-7055
关键词
Atherosclerosis; Autosomal Dominant Polycystic Kidney Disease; C242T Polymorphism; Arterioscler Thromb Vasc Biol; eNOS Gene;
D O I
10.1007/s11883-006-0071-3
中图分类号
学科分类号
摘要
Atherosclerosis, the primary cause of coronary artery disease (CAD), is a multifactorial disease, the molecular etiology of which involves interaction of many genes and environmental factors. Reactive oxygen species are integral to many cellular and biomolecular processes that are active in the transition of incipient fatty streaks into acute coronary syndromes. Animal models of atherosclerosis and correlative data from human studies support the oxidative stress hypothesis of atherosclerosis. However, the association of genetic polymorphisms that underlie enhanced oxidative stress with CAD is controversial. In this review, we discuss polymorphisms in genes that are main sources of reactive oxygen species generation (NAD[P]H oxidase, endothelial nitric oxide synthase, and myeloperoxidase) in mitochondria and the antioxidant enzymes paraoxonase, glutathione reductase, and heme oxygenase. The contribution of defined genetic variants involved in oxidative homeostasis to human atherosclerosis susceptibility is modest because regulation of oxidative stress is multifactorial. However, the contribution of genetic haplotypes in concert with environmental factors is likely significant. A more rigorous characterization of genetic and oxidative phenotypes together with characterization of novel gene polymorphisms may help in early therapeutic intervention for CAD. Copyright © 2006 by Current Science Inc.
引用
收藏
页码:177 / 183
页数:6
相关论文
共 50 条
[1]  
Madamanchi N.R., Moon S.K., Hakim Z.S., Et al., Differential activation of mitogenic signaling pathways in aortic smooth muscle cells deficient in superoxide dismutase isoforms, Arterioscler Thromb Vasc Biol, 25, pp. 950-956, (2005)
[2]  
Liu H., Colavitti R., Rovira I.I., Et al., Redox dependent transcriptional regulation, Circ Res, 97, pp. 967-974, (2005)
[3]  
Marenberg M.E., Risch N., Berkman L.F., Et al., Genetic susceptibility to death from coronary heart disease in a study of twins, N Engl J Med, 330, pp. 1041-1046, (1994)
[4]  
Lusis A.J., Fogelman A.M., Fonarow G.C., Genetic basis of atherosclerotis: Part I: New genes and pathways, Circulation, 110, pp. 1868-1873, (2004)
[5]  
Madamanchi N.R., Vendrov A., Runge M.S., Oxidative stress and vascular disease, Arterioscler Thromb Vasc Biol, 25, pp. 29-38, (2005)
[6]  
Griendling K.K., FitzGerald G.A., Oxidative stress and cardiovascular injury: Part I: Basic mechanisms and in vivo monitoring of ROS, Circulation, 108, pp. 1912-1916, (2003)
[7]  
Griendling K.K., Sorescu D., Ushio-Fukai M., NAD(P)H oxidase: Role in cardiovascular biology and disease, Circ Res, 86, pp. 494-501, (2000)
[8]  
Sorescu D., Weiss D., Lassegue B., Et al., Superoxide production and expression of nox family proteins in human atherosclerosis, Circulation, 105, pp. 1429-1435, (2002)
[9]  
Patterson C., Ruef J., Madamanchi N.R., Et al., Stimulation of a vascular smooth muscle cell NAD(P)H oxidase by thrombin. Evidence that p47(phox) may participate in forming this oxidase in vitro and in vivo, J Biol Chem, 274, pp. 19814-19822, (1999)
[10]  
Soccio M., Toniato E., Evangelista V., Et al., Oxidative stress and cardiovascular risk: The role of vascular NAD(P)H oxidase and its genetic variants, Eur J Clin Invest, 35, pp. 305-314, (2005)